Home > Healthcare > Medical Devices > Therapeutic Devices > blood warmer market
Get a free sample of Blood Warmer Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Blood Warmer Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Based on type, the blood warmer market is segmented into portable blood warmers and non-portable blood warmers. The non-portable blood warmers segment is estimated to witness significant growth accounting for USD 673.9 million in 2022. The upsurge can be attributed to growing aging population base, increased hospital admission rates related to various medical conditions, and better finance for healthcare infrastructure in developing nations. Furthermore, the primary factor for the requirement of IV infusions or blood transfusions include surgical operations and hospital stays. Thus, the growing number of accident rates and increasing surgeries will further spur the market share.
Blood warmer market is bifurcated based on the application including surgery, acute care, newborn care, homecare, and others. The acute care type segment is anticipated to account for grow at a CAGR of 7.5% during the forecast period. The segmental growth is due to the rising rates of mishaps, shootings, and other injuries that are projected to fuel segment expansion. Moreover, blood warmers are necessary for trauma centers and emergency rooms to quickly warm fluids for patients that have suffered serious wounds, trauma, or major blood loss. In these situations, blood warmers allow for fast resuscitation with warmed fluids, assisting in the prevention of hypothermia and enhancing patient outcomes.
The blood warmer market is segmented by end-use into hospitals & clinics, ambulatory services, defence forces, and rescue forces. The hospitals &clinics segment is anticipated to witness high growth potential during the analysis period. Hospitals frequently utilize blood/IV warming systems because they can heat substantial volumes of blood or IV solutions and are also less expensive and simpler to operate. Hospitals are also seen as key purchasers because they have long-term contracts with suppliers of blood and IV fluid warming devices, giving them greater negotiating power, and expanding their potential customer base for product after-sales services. This will contribute considerably towards adoption of blood warmers in hospitals & clinics thereby leading to segment growth.
North America blood warmer market is anticipated to hold high growth potential during the analysis period. The region's market is expanding due to the presence of prominent players, significant government investments in the creation of cutting-edge medical devices, and a favourable reimbursement environment. Additionally, increased spending on the defence industry as well as on search and rescue emergency services, particularly in North America will stimulate the market expansion.
North America held sizable share of the blood warmer industry in 2022 and is projected to expand at a robust CAGR from 2023 -2032 attributed to the strong presence of prominent players, significant government investments, and favorable reimbursement environment.
Blood warmer market size from the acute care type segment is set to witness 7.5% CAGR from 2023-2032 due to the rising rates of mishaps, shootings, and other injuries.
Demand for non-portable blood warmers is estimated to reach USD 673.9 million in 2022 and is expected to grow steadily through 2032 driven by the expanding geriatric population base and the rising hospital admission rates
Blood warmer industry size was more than USD 1.2 billion in 2022 and is estimated to reach over USD 2.5 billion by 2032 owing to increasing adoption for improved patient outcomes, reduced complications risks, and enhanced patient comfort during procedures.